Document Detail

A graphene oxide-photosensitizer complex as an enzyme-activatable theranostic agent.
MedLine Citation:
PMID:  23283113     Owner:  NLM     Status:  Publisher    
The development of a target-activatable "smart" platform with high-affinity and specificity is of great importance for a wide range of biomedical applications. Here, we attempted to develop a new enzyme-activatable graphene oxide-photosensitizer complex as a biologically tunable theranostic agent, making it promising for near-infrared (NIR) fluorescence imaging and photo-induced cancer therapy.
Youngnam Cho; Hyunjin Kim; Yongdoo Choi
Related Documents :
486503 - Dihydropyrimidine amidohydrolase is a zinc metalloenzyme.
21535563 - Use of uv-c treatment to inhibit the microbial growth and maintain the quality of yali ...
6284953 - Changes in enzyme activities of glycerolipid metabolism of guinea-pig cerebral hemisphe...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-3
Journal Detail:
Title:  Chemical communications (Cambridge, England)     Volume:  -     ISSN:  1364-548X     ISO Abbreviation:  Chem. Commun. (Camb.)     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610838     Medline TA:  Chem Commun (Camb)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Molecular Imaging & Therapy Branch, National Cancer Center, 323 Ilsan-ro, Goyang-si, Gyeonggi-do 410-769, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Anaphylaxis as a manifestation of horse allergy.
Next Document:  Asymmetric organocatalytic allylic alkylation of Reissert compounds: a facile access to chiral 1,1-d...